Showing results (101-110 of 223) with videos related to

Sort By:
Pageof 23
Journal of Neuroimmunology|April 28, 2010
The serum and cerebrospinal fluid pharmacokinetics of anakinra after intravenous administration to non-human primatesElizabeth Fox, Nalini Jayaprakash, Tuyet-Hang Pham, et al.
Clinical Breast Cancer|August 30, 2025
Preferences for Breast Cancer Survivorship Programs Among Multiracial and Ethnic WomenLisa Anderson, Oindrila Bhattacharyya, Akia Clark, et al.
The American Surgeon|May 23, 2024
Establishing Geriatric Opiate Use Patterns in TraumaEmily Hammond, Samantha Zhan-Moodie, Viktoriya Sapkalova, et al.
Leukemia & Lymphoma|December 16, 2006
Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144PPaul C Nathan, Trish Whitcomb, Pamela L Wolters, et al.
Cancer Chemotherapy and Pharmacology|July 10, 2019
Population pharmacokinetics of trabectedin in adolescent patients with cancerItalo Poggesi, Belén Valenzuela, Daniele Ouellet, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2021
A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcomaElizabeth Fox, Christine Busch, Alexander DeBernardo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Intrathecal mafosfamide: a preclinical pharmacology and phase I trialSusan M Blaney, Frank M Balis, Stacey Berg, et al.
Pediatric Blood & Cancer|January 3, 2018
Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)Robin E Norris, Elizabeth Fox, Joel M Reid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2010
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancerRonan J Kelly, Deborah Draper, Clara C Chen, et al.
Cancer Medicine|November 27, 2025
A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and CNS TumorsDavid S Shulman, Kieuhoa T Vo, Frank M Balis, et al.
Pageof 23